» Articles » PMID: 24481990

Is Adrenal Venous Sampling Mandatory Before Surgical Decision in Case of Primary Hyperaldosteronism?

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2014 Feb 1
PMID 24481990
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary hyperaldosteronism (PHA) is a cause of secondary arterial hypertension potentially curable by laparoscopic unilateral adrenalectomy. We describe the follow-up of these patients according to their medical or surgical treatment.

Methods: We report a retrospective single-center study of 91 patients with PHA from 1998 to 2012. Treatment was guided by computed tomography (CT) scans. Preoperative adrenal vein sampling (AVS) was performed when the CT scan did not show single solitary unilateral nodules on the adrenal glands. During the follow-up, we considered hypertension to be cured in patients with normal blood pressure without antihypertensive medication (AM), and improvement was defined by a decrease in AM.

Results: A total of 28 patients received only AM. Of the 62 patients who underwent a unilateral adrenalectomy, 46 (74 %) had an adrenal adenoma, 14 (22 %) a hyperplasia, and the adrenal gland was normal in two cases. Hypertension was cured in 24 cases (38 %), and 28 patients (45 %) showed improvement with a reduction in AM. Predictive factors for a cure were gender, age, number of preoperative AMs, preoperative arterial systolic blood pressure, and plasma renin activity. All patients who presented with hypokalemia were cured postoperatively. We performed 38 AVS and nine of these patients were operated on based on the AVS findings, with an improvement of 100 % of arterial blood pressure after surgery.

Conclusion: Laparoscopic unilateral adrenalectomy for PHA cured or improved hypertension in 84 % of patients. Preoperative AVS is mandatory for surgical decision making if the CT scan shows bilateral or no lesions associated with PHA.

Citing Articles

Prognosis of adrenalectomy guided by computed tomography versus adrenal vein sampling in patients with primary aldosteronism: A systematic review and meta-analysis.

Yan Y, Sun H, Qi Y J Clin Hypertens (Greenwich). 2022; 24(2):106-115.

PMID: 35064745 PMC: 8845452. DOI: 10.1111/jch.14395.


A Clinical-Radiomic Nomogram Based on Unenhanced Computed Tomography for Predicting the Risk of Aldosterone-Producing Adenoma.

He K, Zhang Z, Wang Z, Wang Y, Wang Y, Zhang H Front Oncol. 2021; 11:634879.

PMID: 34307119 PMC: 8300014. DOI: 10.3389/fonc.2021.634879.


Experience in identifying the variant adrenal venous anatomy during modified retroperitoneoscopic adrenalectomy.

Hu D, Zhu D, Zhang Y, Wang X J Minim Access Surg. 2021; 17(2):175-179.

PMID: 33723181 PMC: 8083753. DOI: 10.4103/jmas.JMAS_31_20.


Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK).

Lorenz K, Langer P, Niederle B, Alesina P, Holzer K, Nies C Langenbecks Arch Surg. 2019; 404(4):385-401.

PMID: 30937523 DOI: 10.1007/s00423-019-01768-z.


A case report of hyponatremia after surgery for Conn's adenoma.

Furlanis G, Bernardi S, Cavressi M, Zandona L, Carretta R, Fabris B J Renin Angiotensin Aldosterone Syst. 2017; 18(4):1470320317740240.

PMID: 29141492 PMC: 5843937. DOI: 10.1177/1470320317740240.


References
1.
Tresallet C, Salepcioglu H, Godiris-Petit G, Hoang C, Girerd X, Menegaux F . Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. Surgery. 2010; 148(1):129-34. DOI: 10.1016/j.surg.2009.11.020. View

2.
Ishidoya S, Kaiho Y, Ito A, Morimoto R, Satoh F, Ito S . Single-center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling. Urology. 2011; 78(1):68-73. DOI: 10.1016/j.urology.2010.12.042. View

3.
Sywak M, Pasieka J . Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg. 2002; 89(12):1587-93. DOI: 10.1046/j.1365-2168.2002.02261.x. View

4.
Young Jr W . Primary aldosteronism - treatment options. Growth Horm IGF Res. 2003; 13 Suppl A:S102-8. DOI: 10.1016/s1096-6374(03)00064-9. View

5.
Seiler L, Rump L, Schulte-Monting J, Slawik M, Borm K, Pavenstadt H . Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol. 2004; 150(3):329-37. DOI: 10.1530/eje.0.1500329. View